Assignee
OLEMA PHARMACEUTICALS INC
US·7 granted patents·8 pending applications·32 citations·filing 2012–2025
Top patents by PatentIndex Score
15 records- 0192US10624878B2Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugsOLEMA PHARMACEUTICALS INC·Filed 2019·Granted Apr 21, 2020·4 cites·24 claims
- 0292US10292971B2Tetrahydro-1H-pyrido[3,4-b]indole anti-estrogenic drugsOLEMA PHARMACEUTICALS INC·Filed 2016·Granted May 21, 2019·6 cites·29 claims
- 0390US11229630B2Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugsOLEMA PHARMACEUTICALS INC·Filed 2020·Granted Jan 25, 2022·2 cites·19 claims
- 0488US9018244B2Benzopyran compounds, compositions and uses thereofOLEMA PHARMACEUTICALS INC·Filed 2012·Granted Apr 28, 2015·20 cites·50 claims
- 0581US2024226073A9TETRAHYDRO-1H-PYRIDO[3,4-b]INDOLE ANTI-ESTROGENIC DRUGSOLEMA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0676US11672785B2Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugsOLEMA PHARMACEUTICALS INC·Filed 2021·Granted Jun 13, 2023·0 cites·19 claims
- 0774US12428379B2Acylsulfonamide KAT6A inhibitorsOLEMA PHARMACEUTICALS INC·Filed 2024·Granted Sep 30, 2025·0 cites·27 claims
- 0865US2026055103A12,3,4,9-tetrahydro-1h-pyrido[3,4-b]indole derivatives as estrogen receptor modulators for the treatment of cancerOLEMA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0961US2026015327A1Acylsulfonamide kat6a inhibitorsOLEMA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1061US2025214996A1Salts and solid forms of an estrogen receptor antagonistOLEMA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1155US12370181B2Regimens of estrogen receptor antagonistsOLEMA PHARMACEUTICALS INC·Filed 2020·Granted Jul 29, 2025·0 cites·10 claims
- 1255US2025049768A1Methods of treating estrogen receptor-associated diseasesOLEMA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1349US2023129598A1Methods of treating estrogen receptor-associated diseasesOLEMA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1439US2023159619A1Compositions and methods for regulating immune system activityOLEMA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1537US2015197506A1Novel benzopyran compounds, compositions and uses thereofOLEMA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →